Leukemia & Lymphoma, Volume 61, Issue 1 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 61, Issue 1 (2020)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Volume 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
Management of induction failures in newly diagnosed transplant-eligible multiple myeloma
Morie A. Gertz
Pages: 1-3
Published online: 10 Sep 2019
First Page PreviewforManagement of induction failures in newly diagnosed transplant-eligible multiple myeloma | Full Text | References | PDF (406.7 KB) | EPUB
  • 180 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Ultra-low dose radiotherapy for salivary MALT lymphoma: lessons from small numbers
Danielle Rodin, Andrea Ng & Andrew Wirth
Pages: 4-6
Published online: 21 Nov 2019
First Page PreviewforUltra-low dose radiotherapy for salivary MALT lymphoma: lessons from small numbers | Full Text | References | PDF (302.3 KB) | EPUB
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?
Prajwal Dhakal, Jasleen Kaur, Krishna Gundabolu & Vijaya Raj Bhatt
Pages: 7-17
Published online: 18 Jul 2019
AbstractforImmunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents? | Full Text | References | PDF (983.6 KB) | EPUB
  • 493 Views
  • 4 CrossRef citations
  • 0Altmetric

Review Article

Review
The treatment of adolescents and young adults with acute lymphoblastic leukemia
Anjali S. Advani & Rabi Hanna
Pages: 18-26
Published online: 27 Aug 2019
AbstractforThe treatment of adolescents and young adults with acute lymphoblastic leukemia | Full Text | References | PDF (809.9 KB) | EPUB
  • 367 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Article

Article
Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy
Joanna Blocka, Thomas Hielscher, Carsten Mueller-Tidow, Hartmut Goldschmidt & Jens Hillengass
Pages: 27-36
Published online: 19 Aug 2019
AbstractforSalvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2297 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials
Katja Weisel, Istvan Majer, Lucy DeCosta, Albert Oriol, Hartmut Goldschmidt, Heinz Ludwig, Marco Campioni, Zsolt Szabo & Meletios Dimopoulos
Pages: 37-46
Published online: 22 Oct 2019
AbstractforCarfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials | Full Text | References | PDF (1 MB) | EPUB
  • 4181 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Burden of disease progression in patients with multiple myeloma in the US
May Hagiwara, Sumeet Panjabi, Tom Delea, Emre Yucel & Rafael Fonseca
Pages: 47-55
Published online: 07 Aug 2019
AbstractforBurden of disease progression in patients with multiple myeloma in the US | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 4596 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Article
Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study
Rong Deng, Leonid Gibiansky, Tong Lu, Xiaobin Li, Dan Lu, Chunze Li, Sandhya Girish, Jue Wang, Michelle Boyer, Noopur Shankar, Kathryn Humphrey, Kevin J. Freise, Ahmed Hamed Salem, John F. Seymour, Arnon P. Kater & Dale Miles
Pages: 56-65
Published online: 24 Sep 2019
AbstractforExposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 745 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma
Heounjeong Go, Ji-Young Jang, Chul-Woo Kim, Jooryung Huh, Pil-Jong Kim & Yoon Kyung Jeon
Pages: 66-74
Published online: 23 Aug 2019
AbstractforIdentification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 345 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data
Husam Albarmawi, Madhuram Nagarajan, Kai Sun, Aakash Bipin Gandhi, Jean Yared, Karen N. Keating, Sreevalsa Appukkuttan, Avin Yaldo, Mecide Gharibo & Eberechukwu Onukwugha
Pages: 75-83
Published online: 07 Aug 2019
AbstractforCosts associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data | Full Text | References | PDF (891.6 KB) | EPUB | Supplemental
  • 351 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas
Lorenzo Manconi, Elisa Coviello, Filippo Canale, Livia Giannoni, Paola Minetto, Fabio Guolo, Marino Clavio, Riccardo Marcolin, Michele Cea, Antonia Cagnetta, Marco Gobbi, Maurizio Miglino, Filippo Ballerini & Roberto Massimo Lemoli
Pages: 84-90
Published online: 04 Sep 2019
AbstractforDexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas | Full Text | References | PDF (753.6 KB) | EPUB
  • 526 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Articles

Article
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation
Maansi Joshi, John Taper, Cecily Forsyth, Philip Rowlings, Philip Campbell, Philip Crispin, Michael Harvey, Craig Underhill, Angela Bayley, Karen Byth, Gillian Huang & Mark Hertzberg
Pages: 91-97
Published online: 12 Sep 2019
AbstractforOutpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation | Full Text | References | PDF (683.4 KB) | EPUB
  • 386 Views
  • 6 CrossRef citations
  • 0Altmetric

Original Article

Article
Treatment patterns and deep molecular response in chronic phase – chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study
Jorge Cortes, Lynn Huynh, Estella Mendelson, Patricia Brandt, Darshan Dalal, Maral DerSarkissian, Diego Cortina, Sahil Narkhede & Mei Sheng Duh
Pages: 98-107
Published online: 13 Aug 2019
AbstractforTreatment patterns and deep molecular response in chronic phase – chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study | Full Text | References | PDF (950.5 KB) | EPUB
  • 981 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Immunophenotype and function define TCRγδ + T-ALL as a distinct subgroup from TCRαβ + T-ALL patients
Gauri Mirji, Shripad Banavali, Manju Sengar & Shubhada V. Chiplunkar
Pages: 108-117
Published online: 08 Aug 2019
AbstractforImmunophenotype and function define TCRγδ + T-ALL as a distinct subgroup from TCRαβ + T-ALL patients | Full Text | References | PDF (1.9 MB) | EPUB
  • 204 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Unmanipulated haploidentical peripheral blood stem cell transplantation for patients with Philadelphia-negative acute lymphoblastic leukaemia in first complete remission
Feiyan Wang, Tong Liu, Li Wang, Zhenyang Gu, Nan Yang, Lan Luo, Chengying Zhu, Meng Li, Daihong Liu & Chunji Gao
Pages: 118-127
Published online: 13 Sep 2019
AbstractforUnmanipulated haploidentical peripheral blood stem cell transplantation for patients with Philadelphia-negative acute lymphoblastic leukaemia in first complete remission | Full Text | References | PDF (1.1 MB) | EPUB
  • 141 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
The interaction of tumor cells and myeloid-derived suppressor cells in chronic myelogenous leukemia
Hui Xu, Jingjing Liu, Na Shen, Zhe Zhao, Jieke Cui, Shu Zhou, Lin Jiang, Xiaoying Zhu, Ling Tang, Haitao Liang, Wen Liu, Zunmin Zhu, Li Meng & Xiaojian Zhu
Pages: 128-137
Published online: 18 Sep 2019
AbstractforThe interaction of tumor cells and myeloid-derived suppressor cells in chronic myelogenous leukemia | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 172 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia
Claudia Lanvers-Kaminsky, Andreas Niemann, Maria Eveslage, Joachim Beck, Thomas Köhnke, Sonja Martin, Maike de Wit, Bernd Spriewald, Holger Hauspurg, Dieter Hoelzer, Joachim Boos & Nicola Gökbuget
Pages: 138-145
Published online: 03 Sep 2019
AbstractforAsparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia | Full Text | References | PDF (735.3 KB) | EPUB
  • 358 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies
Matthew C. Cheung, Ruth Croxford, Craig C. Earle & Simron Singh
Pages: 146-155
Published online: 22 Aug 2019
AbstractforDays spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies | Full Text | References | PDF (984.6 KB) | EPUB
  • 439 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Comparison of complication rates and incidences associated with different peripherally inserted central catheters (PICC) in patients with hematological malignancies: a retrospective cohort study
Nicholas Scrivens, Elham Sabri, Christopher Bredeson & Sheryl McDiarmid
Pages: 156-164
Published online: 07 Aug 2019
AbstractforComparison of complication rates and incidences associated with different peripherally inserted central catheters (PICC) in patients with hematological malignancies: a retrospective cohort study | Full Text | References | PDF (792.5 KB) | EPUB
  • 1256 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
The detection of bacterial infections in leukemia patients using procalcitionin levels
Jun-Xu Gu, Na Zhang, Shan-Shan Li, Ai-Min Zhang, Yue Yin, Yi-Fan Li & Mei Jia
Pages: 165-170
Published online: 27 Jul 2019
AbstractforThe detection of bacterial infections in leukemia patients using procalcitionin levels | Full Text | References | PDF (728 KB) | EPUB
  • 244 Views
  • 4 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function
Jillian R. Gunther, Chanhyun Park, Bouthaina S. Dabaja, Sarah A. Milgrom, Ruben J. Cruz Chamorro, L. Jeffrey Medeiros, Joseph D. Khoury, Naveen Garg, Behrang Amini, Raphael Steiner, Ranjit Nair, Paolo Strati, Jason R. Westin, Hun Ju Lee, Nathan Fowler, Loretta Nastoupil, Sattva S. Neelapu & Chelsea C. Pinnix
Pages: 171-175
Published online: 02 Aug 2019
First Page PreviewforRadiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function | Full Text | References | PDF (1 MB) | EPUB
  • 497 Views
  • 14 CrossRef citations
  • 0Altmetric
Letter
Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study
Noriko Fukuhara, Go Yamamoto, Hideki Tsujimura, Takaaki Chou, Hirohiko Shibayama, Tomoko Yanai, Kazunori Shibuya & Koji Izutsu
Pages: 176-180
Published online: 22 Aug 2019
First Page PreviewforRetreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1430 Views
  • 12 CrossRef citations
  • 0Altmetric
Letter
Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder
María Isabel Prieto-Conde, Jorge Labrador, Gerardo Hermida, Sara Alonso, Cristina Jiménez, María García-Álvarez, Alejandro Medina, Ana Balanzategui, Miguel Alcoceba, María Eugenia Sarasquete, Noemí Puig, Verónica González, Norma C. Gutiérrez, Ramón García-Sanz, Marcos González-Díaz & María del Carmen Chillón
Pages: 181-184
Published online: 06 Aug 2019
First Page PreviewforGenomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder | Full Text | References | PDF (520.5 KB) | EPUB
  • 346 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation
Eric Wong, Joanne Davis, Rachel Koldej, Jeff Szer, Andrew Grigg & David Ritchie
Pages: 185-188
Published online: 07 Aug 2019
First Page PreviewforNivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation | Full Text | References | PDF (812.8 KB) | EPUB
  • 201 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study
Blazej Ratajczak, Michal Gniot, Anna Przybylowicz-Chalecka, Joanna Czerwinska-Rybak, Mieczyslaw Komarnicki, Krzysztof Lewandowski & Malgorzata Jarmuz-Szymczak
Pages: 189-193
Published online: 07 Aug 2019
First Page PreviewforCharacterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study | Full Text | References | PDF (1.4 MB) | EPUB
  • 144 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Response to trametinib of histiocytosis with an activating PTPN11 mutation
Laure Farnault, Zofia Hélias-Rodzewicz, Geoffroy Venton, Raphaelle Fanciullino, Sophie Gabriel, Lénaïg Mescam, Julien Haroche, Jean Donadieu & Jean-François Emile
Pages: 194-197
Published online: 08 Aug 2019
First Page PreviewforResponse to trametinib of histiocytosis with an activating PTPN11 mutation | Full Text | References | PDF (755.6 KB) | EPUB
  • 345 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma
Dominic P. Decker, Pamela C. Egan, Adam S. Zayac, Diana O. Treaba & Adam J. Olszewski
Pages: 198-201
Published online: 21 Aug 2019
First Page PreviewforTreatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 247 Views
  • 12 CrossRef citations
  • 0Altmetric
Letter
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation
Graham McIlroy, Emmanouil Nikolousis, Nervana Abou-Zeid, Paneesha Shankara, Bhuvan Kishore, Maria Kaparou, Richard Lovell, Shereef Elmoamly, David Davies, Claire Horgan, Amir Shenouda & Alexandros Kanellopoulos
Pages: 202-205
Published online: 11 Aug 2019
First Page PreviewforMixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (445.3 KB) | EPUB
  • 155 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Immunomodulatory drugs in plasma cell diseases: everything has its price
Tamara Berno, Marcello Riva, Marny Fedrigo, Agostino Naso, Mariagiulia Anglani, Chiara Briani & Fausto Adami
Pages: 206-208
Published online: 10 Sep 2019
First Page PreviewforImmunomodulatory drugs in plasma cell diseases: everything has its price | Full Text | References | PDF (836.9 KB) | EPUB
  • 79 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Co-occurrence of BCR-ABL1 rearrangement and CALR mutation in a single leukemic stem cell: evidence that BCR-ABL1 oncogenic addiction prevails over CALR signaling
Estelle Balducci, Safa Sanekli, Patricia Hugues, Mathis Soubeyrand, Claire Borie, Xavier Fund, Christophe Desterke, Cédric Aumont, Jamila Faivre, Annelise Bennaceur-Griscelli & Ali G. Turhan
Pages: 209-212
Published online: 29 Aug 2019
First Page PreviewforCo-occurrence of BCR-ABL1 rearrangement and CALR mutation in a single leukemic stem cell: evidence that BCR-ABL1 oncogenic addiction prevails over CALR signaling | Full Text | References | PDF (875.8 KB) | EPUB
  • 121 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Myeloid neoplasm with eosinophilia and ETV6-JAK2 fusion
James R. Cook, Heesun J. Rogers, Pranil K. Chandra, James L. Prescott & Sudipto Mukherjee
Pages: 213-216
Published online: 04 Sep 2019
First Page PreviewforMyeloid neoplasm with eosinophilia and ETV6-JAK2 fusion | Full Text | References | PDF (1,014.8 KB) | EPUB
  • 158 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
SET-CAN fusion gene as poor prognosis predictor in adult T-cell acute lymphoblastic leukemia
Qianqian Yang, Honglan Qian, Zhenlin Jin, Zhijie Yu, Kang Yu, Shenghui Zhang & Songfu Jiang
Pages: 217-220
Published online: 10 Sep 2019
First Page PreviewforSET-CAN fusion gene as poor prognosis predictor in adult T-cell acute lymphoblastic leukemia | Full Text | References | PDF (724.1 KB) | EPUB
  • 183 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Remarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemia
Yurie Nagai, Shokichi Tsukamoto, Yutaro Hino, Yusuke Isshiki, Miki Yamazaki, Shintaro Izumi, Tatsuzo Mishina, Nagisa Oshima-Hasegawa, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Masahiro Takeuchi, Tohru Iseki, Chiaki Nakaseko & Emiko Sakaida
Pages: 221-224
Published online: 05 Sep 2019
First Page PreviewforRemarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemia | Full Text | References | PDF (836.5 KB) | EPUB
  • 74 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia
Shin Yeu Ong, Colin Phipps, Chandramouli Nagarajan, Tiffany Tang, Soon Thye Lim, Yeow Tee Goh & Yuh Shan Lee
Pages: 225-227
Published online: 05 Aug 2019
First Page PreviewforCell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia | Full Text | References | PDF (579.5 KB) | EPUB | Supplemental
  • 142 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma
Rohit Thummalapalli, Laura A. Sena, John C. Probasco & Douglas E. Gladstone
Pages: 228-230
Published online: 10 Sep 2019
First Page PreviewforCheckpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma | Full Text | References | PDF (299.9 KB) | EPUB
  • 318 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome
Margaret Kelsey Baron, James Dane Osborn, Randa Tao & Catherine J. Lee
Pages: 231-233
Published online: 27 Aug 2019
First Page PreviewforHaploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome | Full Text | References | PDF (782 KB) | EPUB
  • 143 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature
Daniela Cilloni, Giacomo Andreani, Matteo Dragani, Marco De Gobbi & Giuseppe Saglio
Pages: 234-236
Published online: 10 Sep 2019
First Page PreviewforSynergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature | Full Text | References | PDF (475.6 KB) | EPUB
  • 500 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Efficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells
Seiichi Okabe, Yuko Tanaka, Mitsuru Moriyama & Akihiko Gotoh
Pages: 237-239
Published online: 10 Sep 2019
First Page PreviewforEfficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells | Full Text | References | PDF (671.8 KB) | EPUB
  • 193 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Dose reduction and high-risk disease as risk factors for early death in primary CNS lymphoma
Vanja Zeremski, Thomas Fischer & Enrico Schalk
Pages: 240-242
Published online: 08 Aug 2019
First Page PreviewforDose reduction and high-risk disease as risk factors for early death in primary CNS lymphoma | Full Text | References | PDF (414.6 KB) | EPUB
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Letter
Brachial plexopathy following autologous hematopoietic stem cell transplant: an unrecognized complication of autologous transplantation
Zhengrui Xiao, Ana Acuna-Villaorduna & Ioannis Mantzaris
Pages: 243-245
Published online: 20 Aug 2019
First Page PreviewforBrachial plexopathy following autologous hematopoietic stem cell transplant: an unrecognized complication of autologous transplantation | Full Text | References | PDF (410.6 KB) | EPUB
  • 119 Views
  • 0 CrossRef citations
  • 0Altmetric

Correspondence

Letter
Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis
Anna L. Brown, Christopher Hahn, Devendra Hiwase, Lucy A. Godley & Hamish S. Scott
Pages: 246-247
Published online: 24 Oct 2019
CitationforCorrect application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis | Full Text | References | PDF (346.6 KB) | EPUB
  • 213 Views
  • 1 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Reply to Brown et al: ‘Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis’
María Isabel Prieto-Conde, Jorge Labrador, Gerardo Hermida, Sara Alonso, Cristina Jiménez, María García-Alvarez, Alejandro Medina, Ana Balanzategui, Miguel Alcoceba, María Eugenia Sarasquete, Noemí Puig, Verónica González, Norma C. Gutiérrez, Ramón García-Sanz, Marcos González-Díaz & María del Carmen Chillón
Pages: 248-249
Published online: 23 Oct 2019
CitationforReply to Brown et al: ‘Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis’ | Full Text | References | PDF (345.6 KB) | EPUB
  • 73 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles